New Study Explores Trehalose’s Potential Role in Alzheimer’s Disease

by | Sep 14, 2026 | News

 

A newly published study, “Role of AMPK Signaling in the Neuroprotective Effects of Trehalose in Mice With a Pharmacological Model of Alzheimer’s Disease” has explored how trehalose may influence cellular processes associated with Alzheimer’s disease. The experimental research investigated the effects of trehalose in mice with Alzheimer’s disease-like pathology, focusing particularly on its relationship with autophagy and AMPK signalling.

The findings add to a growing body of scientific research investigating trehalose beyond its role as a sugar. They also highlight the complexity of its interactions within biological systems and reinforce the importance of understanding individual sugars according to their unique structures and functions.

 

Looking beyond sweetness

Alzheimer’s disease is associated with several pathological changes in the brain, including the accumulation of amyloid beta proteins, neuroinflammation and progressive cognitive decline.

One area of particular scientific interest is autophagy, a natural cellular process through which cells break down and recycle damaged or unnecessary components. Proper autophagy plays an important role in cellular maintenance, while disruptions to this process have been implicated in several age-related and neurodegenerative diseases.

Trehalose has previously attracted scientific attention for its potential relationship with autophagy. In this latest study, researchers investigated whether trehalose could influence Alzheimer’s disease-related pathology and whether a key metabolic signalling pathway known as AMPK played a role in the effects observed.

 

Investigating trehalose in an experimental model

The researchers used a pharmacological mouse model designed to reproduce features associated with Alzheimer’s disease. Trehalose was administered as a 3% solution daily for 20 days.

The study found that trehalose treatment was associated with reduced amyloid beta accumulation in several regions of the brain and a reduction in markers of neuroinflammation. The researchers also observed improvements in measures of learning and memory.

In addition, trehalose treatment was associated with changes in markers related to autophagy and AMPK activity, suggesting a potential connection between this naturally occurring sugar and important cellular maintenance and energy sensing processes.

 

A more complex picture emerges

AMPK, or AMP-activated protein kinase, acts as an important sensor of cellular energy status. It helps cells respond to changes in energy availability and is involved in regulating a range of metabolic processes, including autophagy.

To understand whether AMPK was responsible for the effects observed, the researchers inhibited the pathway during further experiments.

Interestingly, inhibiting AMPK did not eliminate the effects observed with trehalose treatment. Trehalose continued to reduce amyloid beta accumulation and neuroinflammation and maintained its effects on cognitive performance.

This suggests that while AMPK may be involved in the biological activity of trehalose, it is unlikely to provide the complete explanation.

The findings point towards a more complex picture in which multiple mechanisms may contribute to the effects of trehalose.

 

Why this research matters

Research into Alzheimer’s disease continues to investigate the cellular processes that contribute to the development and progression of neurodegeneration.

The accumulation of abnormal proteins, inflammation and disruptions to cellular maintenance processes are all important areas of investigation. Understanding how molecules interact with these processes may help researchers identify new avenues for future research.

This study contributes to the growing scientific interest surrounding trehalose and its potential interactions with cellular pathways. However, it is important to put the findings into context.

The research was conducted in a mouse model of Alzheimer’s disease-like pathology. It does not demonstrate that consuming trehalose can prevent, treat or reverse Alzheimer’s disease in humans. Further research, including well-designed human clinical studies, is needed to determine whether the mechanisms observed in experimental models have relevance to human health.

 

Understanding the differences between sugars

At Intelligent Sugar, we believe research such as this demonstrates why it is important to move beyond broad generalisations about sugar.

Sugars are not a single, uniform group of molecules. They differ in their chemical structures, how they are metabolised and the roles they can play within biological systems.

Trehalose is an interesting example of this diversity. Scientific research continues to investigate its relationship with processes including autophagy, cellular stress responses and protein aggregation.

Studies such as this contribute to an evolving scientific understanding of how individual sugars can interact with biology in distinctly different ways.

As research continues, one thing remains clear: understanding sugar requires looking beyond sweetness alone. Structure matters, metabolism matters and the biological characteristics of individual sugars matter.

 

 

 

 

Reference

Pupyshev, A. B., Tikhonova, M. A., Tikhonov, M. V., et al. (2026). Role of AMPK Signaling in the Neuroprotective Effects of Trehalose in Mice With a Pharmacological Model of Alzheimer’s Disease. Frontiers in Bioscience (Landmark Edition), 31(8). https://doi.org/10.31083/FBL53657

 

Secret Link